Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer

Summary. Aim: To determine the content of low-spin form of cytochrome P450 in primary tumors and liver metastases of the patients with metastatic colorectal cancer (mCRC) and and assess its prognostic significance. Materials and Methods: The levels of the oxidized and low-spin forms of cyto...

Повний опис

Збережено в:
Бібліографічні деталі
Дата:2023
Автори: Burlaka, A.P., Virko, S.V., Burlaka, A.A., Chernobai, V.А., Yatsyna, O.I., Ganusevich, I.I.
Формат: Стаття
Мова:English
Опубліковано: PH Akademperiodyka 2023
Теми:
Онлайн доступ:https://exp-oncology.com.ua/index.php/Exp/article/view/2020-4-15
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Experimental Oncology

Репозитарії

Experimental Oncology
id oai:ojs2.ex.aqua-time.com.ua:article-160
record_format ojs
institution Experimental Oncology
baseUrl_str
datestamp_date 2023-10-11T16:43:48Z
collection OJS
language English
topic colorectal cancer.
cytochrome P450
liver metastases
metalloproteinase
survival
spellingShingle colorectal cancer.
cytochrome P450
liver metastases
metalloproteinase
survival
Burlaka, A.P.
Virko, S.V.
Burlaka, A.A.
Chernobai, V.А.
Yatsyna, O.I.
Ganusevich, I.I.
Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer
topic_facet colorectal cancer.
cytochrome P450
liver metastases
metalloproteinase
survival
colorectal cancer.
cytochrome P450
liver metastases
metalloproteinase
survival
format Article
author Burlaka, A.P.
Virko, S.V.
Burlaka, A.A.
Chernobai, V.А.
Yatsyna, O.I.
Ganusevich, I.I.
author_facet Burlaka, A.P.
Virko, S.V.
Burlaka, A.A.
Chernobai, V.А.
Yatsyna, O.I.
Ganusevich, I.I.
author_sort Burlaka, A.P.
title Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer
title_short Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer
title_full Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer
title_fullStr Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer
title_full_unstemmed Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer
title_sort cytochrome p450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer
title_alt Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer
description Summary. Aim: To determine the content of low-spin form of cytochrome P450 in primary tumors and liver metastases of the patients with metastatic colorectal cancer (mCRC) and and assess its prognostic significance. Materials and Methods: The levels of the oxidized and low-spin forms of cytochrome P450 in the tissues of patients with mCRC were studied by electron paramagnetic resonance. To detect CYP 1A2 and CYP 1B1 isoforms, Western blot analysis was used. The activity of metalloprotreinases was studied by gelatine zymography. Results: In the liver metastases and tissues adjacent to metastasis, the levels of low-spin forms of cytochrome P450 are lower than in the samples of conventionally normal liver tissue. Western blot analysis revealed that low-spin form of cytochrome P450 in primary tumors and liver metastases detected by electron paramagnetic resonance is attributed largely to CYP 1B1 isoform. The content of low-spin form of cytochrome P450 inversely correlated with the the activity of gelatinases (matrix metalloproteinase-2 and -9). The survival of patients with high levels of the low-spin form of cytochrome P450 in tumor tissues was higher than that of patients with low levels of the enzyme (105 months vs 61 months). Conclusion: In the primary tumors and liver metastases of patients with mCRC, the content of the low-spin form of cytochrome P450 decreased, which correlated inversely with patient’s survival.
publisher PH Akademperiodyka
publishDate 2023
url https://exp-oncology.com.ua/index.php/Exp/article/view/2020-4-15
work_keys_str_mv AT burlakaap cytochromep450contentinprimarytumorsandlivermetastasesofpatientswithmetastaticcolorectalcancer
AT virkosv cytochromep450contentinprimarytumorsandlivermetastasesofpatientswithmetastaticcolorectalcancer
AT burlakaaa cytochromep450contentinprimarytumorsandlivermetastasesofpatientswithmetastaticcolorectalcancer
AT chernobaiva cytochromep450contentinprimarytumorsandlivermetastasesofpatientswithmetastaticcolorectalcancer
AT yatsynaoi cytochromep450contentinprimarytumorsandlivermetastasesofpatientswithmetastaticcolorectalcancer
AT ganusevichii cytochromep450contentinprimarytumorsandlivermetastasesofpatientswithmetastaticcolorectalcancer
first_indexed 2025-07-17T12:15:58Z
last_indexed 2025-07-17T12:15:58Z
_version_ 1837896364400312320
spelling oai:ojs2.ex.aqua-time.com.ua:article-1602023-10-11T16:43:48Z Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer Cytochrome P450 content in primary tumors and liver metastases of patients with metastatic colorectal cancer Burlaka, A.P. Virko, S.V. Burlaka, A.A. Chernobai, V.А. Yatsyna, O.I. Ganusevich, I.I. colorectal cancer., cytochrome P450, liver metastases, metalloproteinase, survival colorectal cancer., cytochrome P450, liver metastases, metalloproteinase, survival Summary. Aim: To determine the content of low-spin form of cytochrome P450 in primary tumors and liver metastases of the patients with metastatic colorectal cancer (mCRC) and and assess its prognostic significance. Materials and Methods: The levels of the oxidized and low-spin forms of cytochrome P450 in the tissues of patients with mCRC were studied by electron paramagnetic resonance. To detect CYP 1A2 and CYP 1B1 isoforms, Western blot analysis was used. The activity of metalloprotreinases was studied by gelatine zymography. Results: In the liver metastases and tissues adjacent to metastasis, the levels of low-spin forms of cytochrome P450 are lower than in the samples of conventionally normal liver tissue. Western blot analysis revealed that low-spin form of cytochrome P450 in primary tumors and liver metastases detected by electron paramagnetic resonance is attributed largely to CYP 1B1 isoform. The content of low-spin form of cytochrome P450 inversely correlated with the the activity of gelatinases (matrix metalloproteinase-2 and -9). The survival of patients with high levels of the low-spin form of cytochrome P450 in tumor tissues was higher than that of patients with low levels of the enzyme (105 months vs 61 months). Conclusion: In the primary tumors and liver metastases of patients with mCRC, the content of the low-spin form of cytochrome P450 decreased, which correlated inversely with patient’s survival. Summary. Aim: To determine the content of low-spin form of cytochrome P450 in primary tumors and liver metastases of the patients with metastatic colorectal cancer (mCRC) and and assess its prognostic significance. Materials and Methods: The levels of the oxidized and low-spin forms of cytochrome P450 in the tissues of patients with mCRC were studied by electron paramagnetic resonance. To detect CYP 1A2 and CYP 1B1 isoforms, Western blot analysis was used. The activity of metalloprotreinases was studied by gelatine zymography. Results: In the liver metastases and tissues adjacent to metastasis, the levels of low-spin forms of cytochrome P450 are lower than in the samples of conventionally normal liver tissue. Western blot analysis revealed that low-spin form of cytochrome P450 in primary tumors and liver metastases detected by electron paramagnetic resonance is attributed largely to CYP 1B1 isoform. The content of low-spin form of cytochrome P450 inversely correlated with the the activity of gelatinases (matrix metalloproteinase-2 and -9). The survival of patients with high levels of the low-spin form of cytochrome P450 in tumor tissues was higher than that of patients with low levels of the enzyme (105 months vs 61 months). Conclusion: In the primary tumors and liver metastases of patients with mCRC, the content of the low-spin form of cytochrome P450 decreased, which correlated inversely with patient’s survival. PH Akademperiodyka 2023-05-30 Article Article application/pdf https://exp-oncology.com.ua/index.php/Exp/article/view/2020-4-15 10.32471/exp-oncology.2312-8852.vol-42-no-4.15310 Experimental Oncology; Vol. 42 No. 4 (2020): Experimental Oncology; 330-332 Експериментальна онкологія; Том 42 № 4 (2020): Експериментальна онкологія; 330-332 2312-8852 1812-9269 10.32471/exp-oncology.2312-8852.vol-42-no-4 en https://exp-oncology.com.ua/index.php/Exp/article/view/2020-4-15/2020-4-15 Copyright (c) 2023 Experimental Oncology https://creativecommons.org/licenses/by-nc/4.0/